Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 135
Filter
Add more filters











Publication year range
1.
Neuroscience ; 406: 50-61, 2019 May 15.
Article in English | MEDLINE | ID: mdl-30826522

ABSTRACT

Despite the high incidence of neuropathic pain, its mechanism remains unclear. Oxytocin (OXT) is an established endogenous polypeptide produced in the supraoptic nucleus (SON) and paraventricular nucleus (PVN) of the hypothalamus. OXT, which is synthesized by OXT neurons in the SON and the magnocellular part of the PVN (mPVN), is delivered into the posterior pituitary (PP), then released into the systemic blood circulation. Meanwhile, OXT-containing neurosecretory cells in the parvocellular part of the PVN (pPVN) are directly projected to the spinal cord and are associated with sensory modulation. In this study, the OXT system in the hypothalamo-neurohypophysial and hypothalamo-spinal pathway was surveyed using a rat neuropathic pain model induced by partial sciatic nerve ligation (PSL). In the present study, we used transgenic rats expressing an OXT-monomeric red fluorescent protein 1 (mRFP1) fusion gene. In a neuropathic pain model, mechanical allodynia was observed, and glial cell activation was also confirmed via immunohistochemistry. In this neuropathic pain model, a significant increase in the OXT-mRFP1 expression was observed in the PP, the SON, mPVN, and pPVN. Furthermore, OXT-mRFP1 granules with positive fluorescent reaction were remarkably increased in laminae I and II of the ipsilateral dorsal horn. Although the plasma concentrations of OXT did not significantly change, a significant increase of the mRNA levels of OXT and mRFP1 in the SON, mPVN, and pPVN were observed. These results suggest that neuropathic pain induced by PSL upregulates hypothalamic OXT synthesis and transportation to the OXTergic axon terminals in the PP and spinal cord.


Subject(s)
Luminescent Proteins/biosynthesis , Neuralgia/metabolism , Oxytocin/metabolism , Paraventricular Hypothalamic Nucleus/metabolism , Pituitary Gland, Posterior/metabolism , Spinal Cord/metabolism , Animals , Luminescent Proteins/analysis , Luminescent Proteins/genetics , Male , Neural Pathways/chemistry , Neural Pathways/metabolism , Oxytocin/analysis , Pain Threshold/physiology , Paraventricular Hypothalamic Nucleus/chemistry , Pituitary Gland, Posterior/chemistry , Rats , Rats, Transgenic , Rats, Wistar , Spinal Cord/chemistry , Supraoptic Nucleus/chemistry , Supraoptic Nucleus/metabolism , Up-Regulation/physiology , Red Fluorescent Protein
2.
Amino Acids ; 47(5): 1053-63, 2015 May.
Article in English | MEDLINE | ID: mdl-25691144

ABSTRACT

TFF3 is a member of the trefoil factor family (TFF) predominantly secreted by mucous epithelia. Minute amounts are also expressed in the immune system and the brain. In the latter, particularly the hypothalamo-pituitary axis has been investigated in detail in the past. Functionally, cerebral TFF3 has been reported to be involved in several processes such as fear, depression, learning and object recognition, and opiate addiction. Furthermore, TFF3 has been linked with neurodegenerative and neuropsychiatric disorders (e.g., Alzheimer's disease, schizophrenia, and alcoholism). Here, using immunohistochemistry, a systematic survey of the TFF3 localization in the adult human brain is presented focusing on extrahypothalamic brain areas. In addition, the distribution of TFF3 in the developing human brain is described. Taken together, neurons were identified as the predominant cell type to express TFF3, but to different extent; TFF3 was particularly enriched in various midbrain and brain stem nuclei. Besides, TFF3 immunostaining staining was observed in oligodendroglia and the choroid plexus epithelium. The wide cerebral distribution should help to explain its multiple effects in the CNS.


Subject(s)
Choroid Plexus/metabolism , Mesencephalon/metabolism , Neurons/metabolism , Oligodendroglia/metabolism , Peptides/genetics , Abortion, Spontaneous , Adult , Amygdala/chemistry , Amygdala/metabolism , Brain Mapping , Cerebellum/chemistry , Cerebellum/metabolism , Cerebral Cortex/chemistry , Cerebral Cortex/metabolism , Choroid Plexus/chemistry , Female , Fetus , Gene Expression , Hippocampus/chemistry , Hippocampus/metabolism , Humans , Hypothalamus/chemistry , Hypothalamus/metabolism , Immunohistochemistry , Male , Mesencephalon/chemistry , Middle Aged , Neurons/chemistry , Oligodendroglia/chemistry , Organ Specificity , Peptides/metabolism , Pituitary Gland/chemistry , Pituitary Gland/metabolism , Pituitary Gland, Posterior/chemistry , Pituitary Gland, Posterior/metabolism , Trefoil Factor-3 , White Matter/chemistry , White Matter/metabolism
3.
J Neurosci Methods ; 201(1): 191-5, 2011 Sep 30.
Article in English | MEDLINE | ID: mdl-21855574

ABSTRACT

Methods currently employed to study the release of hormones such as arginine vasopressin (AVP), while sensitive, suffer from a low temporal resolution such that the monitoring of AVP release on a moment-to-moment basis is not possible. Here, we describe a new approach to indirectly monitor the temporal profile of AVP release from the neurohypophysis of transgenic rats expressing an AVP-eGFP fusion gene. Using fibre-optic probes (termed 'optrodes') we were able to indirectly monitor AVP release via a reporter moiety in real-time. This method is a major advance over current methods used to monitor AVP release. Intravenous administration of hypertonic saline (3M NaCl) induced a rapid (latency of 2-3s) increase in fluorescence detected in the neurohypophysis that lasted on average for 60s - a response that was highly reproducible. Infusion of sodium nitroprusside induced a rapid fall in blood pressure accompanied by a rapid, stimulus-locked increase in fluorescent signal that returned to baseline with the recovery of blood pressure to pre-stimulus levels - again this response was highly reproducible. Withdrawal of blood (to simulate haemorrhage) also resulted in a stimulus-locked increase in fluorescence that return to baseline after the withdrawn blood was returned to the animal. In conclusion, we developed a highly sensitive approach that allows the indirect measurement of AVP release via the monitoring of a reporter gene in real-time. This technology can be adapted to permit the study of a whole array of neurohormones/chemicals in transgenic animals expressing a fluorescent reporter construct.


Subject(s)
Arginine Vasopressin/metabolism , Green Fluorescent Proteins/metabolism , Hypotension/metabolism , Pituitary Gland, Posterior/metabolism , Recombinant Fusion Proteins/metabolism , Saline Solution, Hypertonic/pharmacology , Animals , Arginine Vasopressin/analysis , Female , Green Fluorescent Proteins/analysis , Hypotension/diagnosis , Male , Pituitary Gland, Posterior/chemistry , Pituitary Gland, Posterior/drug effects , Rats , Rats, Transgenic , Recombinant Fusion Proteins/analysis , Time Factors
4.
Neurochem Res ; 36(8): 1407-16, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21484268

ABSTRACT

The dystrophin-associated-protein complex (DAPC) has been extensively characterized in the central nervous system where it is localized both in neuronal and glial cells. Few studies have characterized this complex in the neurohypophysis. To further study this complex in pituicytes, the resident astroglia of the neurophypophysis, we used adult pituicyte cultures and determined the expression and localization of dystrophins/utrophins and the DAPC by RT-PCR, western blotting and immunofluorescence. Our data show that the pituicytes express dystrophins, utrophins and several members of the DAPC including dystroglycans, δ-, γ-sarcoglycans, α-dystrobrevin-1 and α1-syntrophin. Double immunofluorescence analysis shows that laminin colocalizes with dystroglycan, suggesting that similarly to muscle and astrocytes, the DAPC interacts with the extracellular matrix in pituicytes. Collectively these findings show that dystrophins/utrophins and members of the DAPC are expressed in pituicytes where they may form multiprotein complexes and play a role in the retraction-reinsertion of pituicyte endfeet during specific physiological conditions.


Subject(s)
Dystrophin-Associated Protein Complex/metabolism , Dystrophin/metabolism , Pituitary Gland, Posterior/cytology , Protein Isoforms/metabolism , Utrophin/metabolism , Animals , Cells, Cultured , Dystrophin/genetics , Dystrophin-Associated Protein Complex/chemistry , Dystrophin-Associated Protein Complex/genetics , Dystrophin-Associated Proteins/genetics , Dystrophin-Associated Proteins/metabolism , Gene Expression Profiling , Humans , Laminin/genetics , Laminin/metabolism , Male , Pituitary Gland, Posterior/chemistry , Pituitary Gland, Posterior/metabolism , Protein Isoforms/genetics , Rats , Rats, Wistar , Utrophin/genetics
5.
Anim Reprod Sci ; 117(1-2): 111-8, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19394166

ABSTRACT

Orexin A and B, also termed hypocretin 1 and 2, are associated with the stimulation of food intake and arousal. The biological actions of the hormones are mediated via two distinct G protein-coupled receptors, termed orexin receptor 1 (OX1R) and orexin receptor 2 (OX2R). OX1R is selective for orexin A and OX2R binds orexin A and orexin B with similar affinity. The present study analyzed mRNA and protein expressions of OX1R and OX2R in adenohypophysis (AP) and neurohypophysis (NP) of cycling pigs. The tissue samples were harvested on days 2-3, 10-12, 14-16, and 17-19 of the oestrous cycle. Using quantitative real-time PCR higher OX1R gene expression was detected in AP on days 2-3 relative to days 10-12, 14-16 and 17-19 (p<0.05). In NP the OX1R mRNA level was elevated on days 10-12 compared to the remaining stages (p<0.05). OX2R gene expression in AP was the lowest on days 10-12 (p<0.05 compared to days 2-3 and 17-19) and the expression peak occurred on days 17-19 (p<0.05 vs. the all studied stages). In NP the highest (p<0.05) expression of OX2R mRNA was noted on days 17-19 in relation to the remaining periods. OX1R protein content in AP was greatest on days 10-12 (p<0.05), whereas in NP it was greatest on days 2-3 and 14-16 (p<0.05 vs. days 10-12 and 17-19). In both cases the lowest OX1R protein expression was observed during follicular phase (p<0.05 in relation to three remaining studied stages). OX2R protein in AP was lower (p<0.05) on days 2-3 and 14-16 compared to days 10-12 and 17-19. In NP the lowest (p<0.05) expression of this protein was on days 17-19 and the highest on days 10-12 (p<0.05 compared to days 2-3 and 17-19). In summary, the present findings provide the first evidence that OX1R and OX2R mRNAs and proteins occur in the pituitary of the pig and indicate the dependence of orexin receptor expression on the endocrine reproductive state.


Subject(s)
Estrous Cycle/metabolism , Gene Expression/physiology , Pituitary Gland/metabolism , Receptors, G-Protein-Coupled/genetics , Receptors, Neuropeptide/genetics , Swine/metabolism , Animals , Blotting, Western , Female , Orexin Receptors , Pituitary Gland/chemistry , Pituitary Gland, Anterior/chemistry , Pituitary Gland, Posterior/chemistry , Polymerase Chain Reaction , RNA, Messenger/analysis , Receptors, G-Protein-Coupled/analysis , Receptors, Neuropeptide/analysis
6.
Science ; 325(5938): 328-32, 2009 Jul 17.
Article in English | MEDLINE | ID: mdl-19541956

ABSTRACT

Amyloids are highly organized cross-beta-sheet-rich protein or peptide aggregates that are associated with pathological conditions including Alzheimer's disease and type II diabetes. However, amyloids may also have a normal biological function, as demonstrated by fungal prions, which are involved in prion replication, and the amyloid protein Pmel17, which is involved in mammalian skin pigmentation. We found that peptide and protein hormones in secretory granules of the endocrine system are stored in an amyloid-like cross-beta-sheet-rich conformation. Thus, functional amyloids in the pituitary and other organs can contribute to normal cell and tissue physiology.


Subject(s)
Amyloid/chemistry , Peptide Hormones/chemistry , Pituitary Gland/chemistry , Pituitary Hormones/chemistry , Secretory Vesicles/chemistry , Adrenocorticotropic Hormone/chemistry , Adrenocorticotropic Hormone/metabolism , Amyloid/metabolism , Animals , Cell Survival , Corticotropin-Releasing Hormone/chemistry , Corticotropin-Releasing Hormone/metabolism , Heparin, Low-Molecular-Weight/chemistry , Humans , Hydrogen-Ion Concentration , Mice , Neurons/cytology , Neurons/physiology , Peptide Hormones/metabolism , Pituitary Gland, Anterior/chemistry , Pituitary Gland, Anterior/metabolism , Pituitary Gland, Posterior/chemistry , Pituitary Gland, Posterior/metabolism , Pituitary Hormones/metabolism , Protein Conformation , Rats , Secretory Vesicles/metabolism , Sheep , Urocortins/chemistry , Urocortins/metabolism , beta-Endorphin/chemistry , beta-Endorphin/metabolism
7.
Hum Pathol ; 40(3): 435-40, 2009 Mar.
Article in English | MEDLINE | ID: mdl-18992914

ABSTRACT

A broad spectrum of neoplasms affects the sellar region. Among these, gliomas are rare, most being tumors of pituicytes such as granular cell tumor and pituicytoma. Only 4 ependymomas of the human sellar region have been reported to date and all have had classic histologic features. Herein, we describe the clinicopathologic features of a sellar, low-grade ependymoma with unusual histology, but classic ultrastructural features, occurring in an elderly patient and thus expanding the spectrum of reported cases. The literature is reviewed and concepts of histogenesis are explored, particularly an origin in "ependymal pituicytes." The concept that sellar ependymoma is pituicyte-derived is explored.


Subject(s)
Ependymoma/pathology , Pituitary Gland, Posterior/pathology , Pituitary Neoplasms/pathology , Sella Turcica/pathology , Aged , Biomarkers, Tumor/analysis , Diagnosis, Differential , Ependymoma/chemistry , Ependymoma/surgery , Humans , Immunoenzyme Techniques , Intermediate Filaments/ultrastructure , Male , Meningioma/diagnosis , Microscopy, Electron, Transmission , Pituitary Gland, Posterior/chemistry , Pituitary Gland, Posterior/surgery , Pituitary Neoplasms/chemistry , Pituitary Neoplasms/surgery , Sarcoma/diagnosis , Sella Turcica/chemistry , Sella Turcica/surgery , Tomography, X-Ray Computed
8.
J Neurosci Methods ; 163(2): 226-34, 2007 Jul 30.
Article in English | MEDLINE | ID: mdl-17452053

ABSTRACT

The objective of this study was to develop a method that could reliably determine the arginine vasopressin (AVP) and/or oxytocin (OT) content of individual rat neurohypophysial terminals (NHT) >or=5 microm in diameter, the size used for electrophysiological recordings. We used a commercially available, highly sensitive enzyme-linked immunoassay (ELISA) kit with a sensitivity of 0.25 pg to AVP and of 1.0pg to OT. The NHT content of AVP (2.21+/-0.10 pg) was greater than OT (1.77+/-0.08 pg) and increased with terminal size. AVP-positive terminals (10.2+/-0.21 microm) were larger in diameter than OT-positive terminals (9.1+/-0.24 microm). Immunocytochemical techniques indicated that a higher percentage (58%) of smaller terminals contained OT, and that a higher percentage (42%) of larger NHTs were colabeled. Similar percentages of AVP-positive terminals were obtained between immunocytochemical (73%) and ELISA (72%) methods when NHTs were assayed for AVP alone, but there was a higher percentage of OT terminals when using immunocytochemistry (43%) compared to ELISA (26%). The percent of AVP-positive (60%) and OT-positive (18%) terminals decreased when NHT were assayed for both AVP and OT. Therefore, the best method to reliably identify AVP-positive NHTs is to assay only for AVP, since this allows the conclusion that AVP-negative terminals contain only OT.


Subject(s)
Biological Assay/methods , Neurochemistry/methods , Neuropeptides/analysis , Pituitary Gland, Posterior/chemistry , Presynaptic Terminals/chemistry , Animals , Arginine Vasopressin/analysis , Enzyme-Linked Immunosorbent Assay/methods , Immunohistochemistry/methods , Male , Neural Pathways/chemistry , Oxytocin/analysis , Paraventricular Hypothalamic Nucleus/chemistry , Rats , Rats, Sprague-Dawley , Supraoptic Nucleus/chemistry , Synaptic Transmission/physiology
9.
J Gen Virol ; 88(Pt 3): 1068-1072, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17325383

ABSTRACT

By using high-sensitivity Western blotting and immunohistochemistry, pituitary glands from patients with sporadic and variant Creutzfeldt-Jakob disease (sCJD and vCJD, respectively) were analysed for the presence of the protease-resistant form of the prion protein (PrPres). PrPres was detected in a greater proportion of vCJD pituitaries than sCJD pituitaries and was localized predominantly in the neurohypophysis. PrPres was also detected in a recurrent pituitary adenoma from an sCJD patient. Immunohistochemical analysis showed sparse positive labelling, predominantly in folliculostellate cells, in vCJD and sCJD adenohypophyses. The PrPres glycosylation pattern in the vCJD neurohypophyses showed a predominance of the unglycosylated band, which differed markedly from patterns found in all other vCJD tissues. The presence of PrPres in the pituitary of CJD patients at autopsy suggests that human growth hormone-related iatrogenic CJD may have indeed resulted from infectivity in collected pituitaries rather than necessarily from contamination of pituitary pools by adjacent brain tissue.


Subject(s)
Creutzfeldt-Jakob Syndrome/metabolism , Creutzfeldt-Jakob Syndrome/pathology , Pituitary Gland/chemistry , Prions/analysis , Blotting, Western , Glycosylation , Humans , Immunohistochemistry , Pituitary Gland/pathology , Pituitary Gland, Anterior/chemistry , Pituitary Gland, Anterior/pathology , Pituitary Gland, Posterior/chemistry , Pituitary Gland, Posterior/pathology
10.
Pathol Int ; 55(11): 745-9, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16271088

ABSTRACT

Pituicytoma is a rare benign neoplasm, occurring in the sellar and suprasellar regions. Reported herein is a case of asymptomatic pituicytoma, discovered at autopsy, in a 54-year-old Japanese woman. This is the first case report of pituicytoma, found incidentally at autopsy (incidentaloma), in which whole-mounted sections are available for histological and immunohistochemical studies. Grossly, the bisected pituitary gland revealed a round, white to light tan, 7 mm-diameter nodule. Microscopically, whole-mounted sections revealed a well-circumscribed nodule with no fibrous capsule, located mainly in the neurohypophysis and partially compressing the adenohypophysis. The tumor was composed primarily of bipolar, occasionally unipolar, cells with syncytial fibrillary cytoplasm, arranged in short curvilinear fascicles and/or storiform patterns. Unusual histological features were seen, which included a few groups of large pleomorphic tumor cells with abundant, glassy, eosinophilic cytoplasm, occasionally associated with multinucleated giant tumor cells, and scattered Herring bodies within the tumor. Immunohistochemically, the tumor showed diffuse strong expression of glial fibrillary acidic protein, S-100 protein, and vimentin. Epithelial membrane antigen immunoreactivity was focally observed, mainly in the large tumor cells. Distinction from other intrasellar tumors (granular cell tumor and pilocytic astrocytoma) is important. Because the immunohistochemical profiles of these tumors are similar, histological findings are crucial for distinction.


Subject(s)
Incidental Findings , Pituitary Neoplasms/pathology , Autopsy , CD56 Antigen/analysis , CD56 Antigen/immunology , Female , Glial Fibrillary Acidic Protein/analysis , Glial Fibrillary Acidic Protein/immunology , Humans , Immunohistochemistry , Middle Aged , Mucin-1/analysis , Mucin-1/immunology , Pituitary Gland, Posterior/chemistry , Pituitary Gland, Posterior/pathology , Pituitary Neoplasms/chemistry , Pituitary Neoplasms/diagnosis , S100 Proteins/analysis , S100 Proteins/immunology , Vimentin/analysis , Vimentin/immunology
11.
Peptides ; 25(6): 967-74, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15203243

ABSTRACT

We examined the galanin-like peptide (GALP) gene expression in the arcuate nucleus (ARC) and posterior pituitary (PP) in 6- and 18-week-old male obese fa/fa rats. GALP mRNA in the ARC in fa/fa rats was significantly decreased in 6- and 18-week-old and GALP mRNA in the PP in fa/fa rats was significantly increased in 18-week-old compared to lean Fa/? rats. Insulin treatment in hyperglycemic fa/fa rats partially reversed those changes. These results suggest that the GALP gene expression in fa/fa rats might be regulated in part by leptin-independent mechanisms.


Subject(s)
Arcuate Nucleus of Hypothalamus/metabolism , Galanin-Like Peptide/metabolism , Obesity/metabolism , Pituitary Gland, Posterior/metabolism , Animals , Arcuate Nucleus of Hypothalamus/chemistry , Blood Glucose/analysis , Galanin-Like Peptide/genetics , Gene Expression Regulation/genetics , Hyperglycemia/metabolism , Insulin/pharmacology , Leptin/metabolism , Male , Neuropeptide Y/genetics , Neuropeptide Y/metabolism , Obesity/genetics , Pituitary Gland, Posterior/chemistry , Pro-Opiomelanocortin/genetics , Pro-Opiomelanocortin/metabolism , RNA, Messenger/analysis , RNA, Messenger/metabolism , Rats , Rats, Mutant Strains
12.
Anat Rec A Discov Mol Cell Evol Biol ; 277(2): 275-86, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15052655

ABSTRACT

The three-dimensional architecture of collagen fibrils in the connective tissue framework and the distribution of collagen types in the goat hypophysis were studied by the cell maceration method in combination with scanning electron microscopy (SEM) and immunohistochemistry. The pars distalis of the adenohypophysis consisted of many cell clusters. SEM revealed that the wall of cell clusters appeared as various-sized flat bundles of collagen fibrils woven in a basket-like configuration. In the pars tuberalis, the aggregates of collagen fibrils were denser and bundles thicker compared to the pars distalis. The density of collagen fibrils changed from the pars tuberalis to pars distalis without a distinct border. The collagen framework in the pars intermedia was mainly divided into three parts, the dorsal region with large hollows, the middle region, and the ventral sheet facing the cavum hypophysis. In the lobus nervosus of the neurohypophysis, the collagen network exhibited a sponge-like appearance at low magnification. Collagen fibrils of various sizes consisted of loose wavy bundles distributed around the cavities. Immunohistochemistry revealed types I, III, IV, V, and VI collagen throughout the hypophysis. It is concluded that to maintain structural and functional integration, the components of collagen are in different configurations throughout the regions of the goat hypophysis.


Subject(s)
Collagen/ultrastructure , Goats/anatomy & histology , Pituitary Gland, Anterior/anatomy & histology , Pituitary Gland, Posterior/anatomy & histology , Animals , Collagen/chemistry , Collagen/classification , Female , Imaging, Three-Dimensional , Male , Pituitary Gland, Anterior/chemistry , Pituitary Gland, Anterior/ultrastructure , Pituitary Gland, Posterior/chemistry , Pituitary Gland, Posterior/ultrastructure , Tissue Distribution
13.
Hypertension ; 42(5): 962-7, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14568996

ABSTRACT

Gamma-melanocyte-stimulating hormone (gamma-MSH) is a natriuretic peptide derived from proopiomelanocortin (POMC) in the pituitary neurointermediate lobe (NIL); its plasma concentration in rats doubles after ingestion of a high (HSD; 8% NaCl) compared with a low sodium diet (LSD; 0.07%). Because NIL function is regulated through dopaminergic pathways, we asked whether dopaminergic stimulation with bromocriptine (5 mg/kg IP daily for 1 week) or inhibition with haloperidol (5 mg/kg IP for 1 week) alters the gamma-MSH response to a HSD. In vehicle-treated rats, plasma gamma-MSH and NIL gamma-MSH content on the HSD were both markedly elevated over values in rats on the LSD (P<0.001); no difference in mean arterial pressure (MAP) occurred. In haloperidol-treated rats on the LSD, both plasma gamma-MSH and NIL gamma-MSH content were greater than in vehicle-treated rats (P<0.05) and did not increase further on the HSD; MAP was also no different. In bromocriptine-treated rats, neither plasma gamma-MSH nor NIL gamma-MSH content increased on the HSD versus LSD, and MAP was markedly elevated on the HSD (132+/-3 versus 106+/-3 mm Hg, P<0.001). Intravenous infusion of gamma-MSH (0.4 pmol/min) to bromocriptine-treated rats on the HSD restored plasma gamma-MSH concentration to a level appropriate for the HSD and lowered MAP from 131+/-6 to 108+/-5 mm Hg (P<0.01). These results demonstrate that the increases in NIL content and plasma concentration of gamma-MSH normally occurring during ingestion of the HSD are prevented by dopaminergic suppression of NIL function. This results in deficiency of gamma-MSH on the HSD and is accompanied by elevated blood pressure, which is corrected by infusion of the peptide. gamma-MSH may be an important component in the normal response to a HSD; interruption of this response leads to salt-sensitive hypertension.


Subject(s)
Hypertension/chemically induced , Sodium Chloride/toxicity , gamma-MSH/antagonists & inhibitors , Animals , Atrial Natriuretic Factor/blood , Blood Pressure/drug effects , Bromocriptine/pharmacology , Dopamine Agonists/pharmacology , Dopamine Antagonists/pharmacology , Haloperidol/pharmacology , Hypertension/metabolism , Hypertension/physiopathology , Infusions, Intravenous , Male , Pituitary Gland, Posterior/chemistry , Rats , Rats, Sprague-Dawley , Renin/blood , Sodium/urine , gamma-MSH/blood , gamma-MSH/pharmacology
14.
J Biol Chem ; 278(21): 19280-5, 2003 May 23.
Article in English | MEDLINE | ID: mdl-12639960

ABSTRACT

Physiological activation of the hypothalamo-neurohypophyseal system (HNS) by dehydration results is a massive release of vasopressin (VP) from the posterior pituitary. This is accompanied by a functional remodeling of the HNS. In this study we used cDNA arrays in an attempt to identify genes that exhibit differential expression in the hypothalamus following dehydration. Our study revealed nine candidate genes, including interleukin-6 (IL-6) as a putative novel secretory product of HNS worthy of further analysis. In situ hybridization and immunocytochemistry confirmed that IL-6 is robustly expressed in the supraoptic (SON) and the paraventricular (PVN) nuclei of the hypothalamus. By double staining immunofluorescence we showed that IL-6 is largely co-localized with VP in the SON and PVN. In situ hybridization, immunocytochemistry, and Western blotting all revealed IL-6 up-regulation in the SON and PVN following dehydration, thus validating the array data. The same dehydration stimulus resulted in an increase in IL-6 immunoreactivity in the axons of the internal zone of the median eminence and a marked reduction in IL-6-like material in the posterior pituitary gland. We thus suggest that IL-6 takes the same secretory pathway as VP and is secreted from the posterior pituitary following a physiological stimulus.


Subject(s)
Dehydration/physiopathology , Hypothalamus/metabolism , Interleukin-6/genetics , Interleukin-6/metabolism , Oligonucleotide Array Sequence Analysis , Pituitary Gland, Posterior/metabolism , Animals , Axons/chemistry , Blotting, Western , Fluorescent Antibody Technique , Gene Expression , Gene Expression Regulation , Hypothalamus/chemistry , Immunohistochemistry , In Situ Hybridization , Interleukin-6/analysis , Male , Median Eminence/ultrastructure , Paraventricular Hypothalamic Nucleus/chemistry , Pituitary Gland, Posterior/chemistry , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Supraoptic Nucleus/chemistry , Vasopressins/analysis , Vasopressins/metabolism
15.
J Neuroendocrinol ; 15(2): 141-9, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12535156

ABSTRACT

Vasopressin secreted by magnocellular neurones of the hypothalamic supraoptic and paraventricular nuclei is essential for water balance. In this study, we examined magnocellular neurone responses to osmotic stimulation in vehicle-injected controls or rats receiving an intraperitoneal (i.p.) injection of 250 microg/100 g of lipopolysaccharide (LPS), 3 h or 6 h earlier. LPS injection had no effect on plasma vasopressin concentrations in control rats but it caused marked and transient potentiation of the responses to a single i.p. injection of hypertonic saline (five- and two-fold, 3 and 6 h after LPS, respectively). The enhancement of plasma vasopressin responses was independent of plasma sodium concentrations or changes in blood pressure. Basal vasopressin mRNA expression in the paraventricular and supraoptic nuclei decreased slightly 6 h after LPS injection, without changes in vasopressin transcription as indicated by vasopressin heteronuclear (hn) RNA levels. Parvocellular neurones showed expected increases in vasopressin hnRNA expression following LPS injection and a further increase after i.p. hypertonic saline injection (due to the painful component). In contrast to magnocellular vasopressin mRNA expression, the effects of LPS and hypertonic saline injections in parvocellular neurones were additive and not synergistic. Light microscopic immunohistochemical examination revealed an increase in size of vasopressin but not oxytocin axonal terminals in the neural lobe 3 h after LPS injection. Osmotic stimulation caused marked depletion of vasopressin immunoreactivity in axonal terminals of the neural lobe in both control and LPS-pretreated rats. The changes in vasopressin axon terminals were accompanied by induction of interleukin (IL)-1 beta and IL-6 in the posterior pituitary. The data show that endotoxemia causes morphological and functional alterations of the hypothalamic neurohypophyseal system, resulting in facilitation rather than inhibition of vasopressin synthesis, and secretion in response to osmotic stimulation.


Subject(s)
Hypothalamus, Anterior/metabolism , Lipopolysaccharides/pharmacology , Paraventricular Hypothalamic Nucleus/metabolism , Saline Solution, Hypertonic/pharmacology , Vasopressins/genetics , Water-Electrolyte Balance/drug effects , Animals , Antibodies , Blood Pressure/drug effects , Drug Synergism , Gene Expression/drug effects , Hypothalamus, Anterior/drug effects , Interleukin-1/genetics , Interleukin-6/genetics , Male , Oxytocin/analysis , Oxytocin/immunology , Paraventricular Hypothalamic Nucleus/drug effects , Pituitary Gland, Posterior/chemistry , Pituitary Gland, Posterior/physiology , RNA Precursors/analysis , RNA, Messenger/analysis , Rats , Rats, Wistar , Sodium/blood , Transcription, Genetic/drug effects , Vasopressins/blood , Vasopressins/metabolism
16.
J Physiol Pharmacol ; 54(4): 625-41, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14726616

ABSTRACT

Galanin (Gal) as a neuropeptide with widespread distribution in the central nervous system may be involved in the mechanisms of vasopressin (AVP) and oxytocin (OT) release from the hypothalamo-neurohypophysial system. Vasopressin and oxytocin content in the hypothalamus and neurohypophysis as well as plasma level of both neurohormones were studied after galanin treatment in euhydrated and dehydrated rats. In not dehydrated rats intracerebroventricular (i.c.v.) injections of Gal did not affect the hypothalamic and neurohypophysial OT content, however, distinctly increased plasma OT concentration. In the same animals Gal diminished the hypothalamic AVP content but was without the effect on neurohypophysial AVP storage; plasma AVP level then raised. Galanin, administered i.c.v. to rats deprived of water, distinctly inhibited AVP and OT release from the hypothalamo-neurohypophysial system. Simultaneously, plasma AVP and OT level was significantly diminished after Gal treatment in dehydrated rats. These results suggest that modulatory effect of galanin on vasopressin and oxytocin release depends on the actual state of water metabolism. Gal acts as an inhibitory neuromodulator of AVP and OT secretion under conditions of the dehydration but stimulates this process in the state of equilibrated water metabolism.


Subject(s)
Dehydration/metabolism , Galanin/pharmacokinetics , Hypothalamo-Hypophyseal System/drug effects , Oxytocin/metabolism , Vasopressins/metabolism , Animals , Body Water/metabolism , Dehydration/physiopathology , Drug Administration Schedule , Galanin/administration & dosage , Hypothalamo-Hypophyseal System/metabolism , Hypothalamus/chemistry , Hypothalamus/drug effects , Hypothalamus/metabolism , Injections, Intraventricular , Male , Oxytocin/drug effects , Pituitary Gland, Posterior/chemistry , Pituitary Gland, Posterior/drug effects , Pituitary Gland, Posterior/metabolism , Radioimmunoassay/methods , Rats , Rats, Wistar , Vasopressins/drug effects
17.
J Neurosci ; 22(16): 6891-9, 2002 Aug 15.
Article in English | MEDLINE | ID: mdl-12177187

ABSTRACT

Two different families of Na+/Ca2+ exchangers, K+-independent NCX and K+-dependent NCKX, are known. Exploiting the outward K+ gradient, NCKX is able to extrude Ca2+ more efficiently than NCX, even when the Na+ gradient is reduced. The NCKX, which was originally thought to be limited to the retinal photoreceptor, was shown recently to be widely distributed in the brain. We investigated the contribution of Na+/Ca2+ exchange to Ca2+ clearance mechanisms in neurohypophysial (NHP) axon terminals, using patch-clamp and microfluorometry techniques. In the presence of internal K+, Ca2+ decay was significantly slowed by the removal of external Na+, indicative of the role of Na+/Ca2+ exchange. As internal [K+] was decreased, Ca2+ decay rate and its dependence on Na+ were greatly attenuated. In the absence of internal K+, Ca2+ decay rate was little affected by Na+ removal. Quantitative analysis using Ca2+ decay rate constant indicated that >60% of Ca2+ extrusion is mediated by Na+/Ca2+ exchange when peak [Ca2+] level is higher than 500 nm, and approximately 90% of Na+/Ca2+ exchange activity is K+ dependent. In situ hybridization confirmed the expression of NCKX2 transcripts in the supraoptic nucleus in which soma of NHP axon terminals are located. To our knowledge, this is the first report to show the significant role of K+-dependent Na+/Ca2+ exchange in neuronal cells other than photoreceptors. Considering that axon terminals are subject to an invasion by high-frequency Na+ spikes, which may lower Na+ gradients, the presence of NCKX may have a functional significance in intracellular Ca2+ regulation.


Subject(s)
Calcium/metabolism , Pituitary Gland, Posterior/metabolism , Potassium/metabolism , Presynaptic Terminals/metabolism , Sodium/metabolism , Animals , Calcium Signaling/physiology , Fluorescent Dyes , Fura-2 , Ion Transport/physiology , Paraventricular Hypothalamic Nucleus/chemistry , Paraventricular Hypothalamic Nucleus/metabolism , Patch-Clamp Techniques , Pituitary Gland, Posterior/chemistry , Presynaptic Terminals/chemistry , RNA, Messenger/analysis , RNA, Messenger/biosynthesis , Rats , Sodium-Calcium Exchanger/biosynthesis , Sodium-Calcium Exchanger/genetics , Supraoptic Nucleus/chemistry , Supraoptic Nucleus/metabolism , Thalamus/chemistry , Thalamus/metabolism
18.
Neuron ; 34(3): 399-410, 2002 Apr 25.
Article in English | MEDLINE | ID: mdl-11988171

ABSTRACT

The sigma receptor is a novel protein that mediates the modulation of ion channels by psychotropic drugs through a unique transduction mechanism depending neither on G proteins nor protein phosphorylation. The present study investigated sigma receptor signal transduction by reconstituting responses in Xenopus oocytes. Sigma receptors modulated voltage-gated K+ channels (Kv1.4 or Kv1.5) in different ways in the presence and absence of ligands. Association between Kv1.4 channels and sigma receptors was demonstrated by coimmunoprecipitation. These results indicate a novel mechanism of signal transduction dependent on protein-protein interactions. Domain accessibility experiments suggested a structure for the sigma receptor with two cytoplasmic termini and two membrane-spanning segments. The ligand-independent effects on channels suggest that sigma receptors serve as auxiliary subunits to voltage-gated K+ channels with distinct functional interactions, depending on the presence or absence of ligand.


Subject(s)
Phenazocine/analogs & derivatives , Potassium Channels, Voltage-Gated , Potassium Channels/metabolism , Receptors, sigma/metabolism , Signal Transduction/physiology , Animals , Antipsychotic Agents/pharmacology , Kv1.4 Potassium Channel , Kv1.5 Potassium Channel , Ligands , Oocytes/drug effects , Oocytes/physiology , Patch-Clamp Techniques , Phenazocine/pharmacology , Pituitary Gland, Posterior/chemistry , Pituitary Gland, Posterior/metabolism , Potassium Channels/genetics , Protein Structure, Secondary , Protein Subunits , Rats , Receptors, sigma/chemistry , Receptors, sigma/genetics , Recombinant Fusion Proteins/metabolism , Xenopus laevis
19.
Neurosci Lett ; 317(2): 65-8, 2002 Jan 11.
Article in English | MEDLINE | ID: mdl-11755241

ABSTRACT

A galanin-like peptide (GALP) was recently isolated as a ligand of GalR2, a galanin receptor subtype. The GALP mRNA is expressed in the arcuate nucleus of the hypothalamus and the posterior pituitary (PP). In this study, we demonstrated the localization of GALP-immunoreactive (-ir) cells in the rat PP. In normal conditions, a few GALP-ir cells were detected in the PP, and these cells increased on dehydration for 4 days. The GALP-immunopositive reaction was dramatically enhanced by the intraperitoneal injection of colchicine. For the identification of GALP-ir cells in the PP, we performed electron microscopic observation, and also double immunocytochemical staining for GALP and S-100 protein. Both studies clearly indicated that the GALP-ir cells in the PP are pituicytes.


Subject(s)
Nerve Tissue Proteins/analysis , Pituitary Gland, Posterior/chemistry , Animals , Antibodies, Monoclonal/immunology , Biomarkers , Biotinylation , Colchicine/pharmacology , Dehydration/genetics , Dehydration/metabolism , Galanin-Like Peptide , Immunoenzyme Techniques , Male , Microscopy, Electron , Nerve Tissue Proteins/immunology , Pituitary Gland, Posterior/cytology , Rats , Rats, Wistar , S100 Proteins/analysis
SELECTION OF CITATIONS
SEARCH DETAIL